Medicover AB (LTS:0RPS) Notes Receivable: kr0 Mil (As of Mar. 2026)


LTS:0RPS Medicover AB LTS:0RPS
89 GF Score
Price kr238.00
GF Value kr234.40
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Medicover AB Notes Receivable?

Medicover AB LTS:0RPS +0.42% 89 Notes Receivable is kr0 Mil as of Mar. 2026. GuruFocus rates LTS:0RPS with a GF Score™ of 89/100 and a GF Value™ of kr234.40 (Fairly Valued). The stock has 5 warning signs investors should review.

Medicover AB's Notes Receivable for the quarter that ended in Mar. 2026 was kr0 Mil.

Medicover AB Notes Receivable Historical Data

* Premium members only.

The historical data trend for Medicover AB's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicover AB Notes Receivable Chart

Medicover AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medicover AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LTS:0RPS
89GF Score
Medicover AB LTS:0RPS
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicover AB Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of kr0 Mil mean?
Medicover AB (LTS:0RPS) has a Notes Receivable of kr0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Medicover AB and its competitors.
Is Medicover AB's Notes Receivable too high?
Medicover AB's current Notes Receivable is kr0 Mil. Overall, Medicover AB has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medicover AB's Notes Receivable compare to HCA and THC?
Medicover AB's Notes Receivable of kr0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Medicover AB and its competitors. Medicover AB's current Notes Receivable is kr0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicover AB stock overvalued right now?
Based on GuruFocus' analysis, Medicover AB (LTS:0RPS) is currently considered Fairly Valued. The stock's GF Value™ is kr234.40, compared to a current price of kr238.00 — trading 1.5% above its estimated fair value. The current Notes Receivable is kr0 Mil. Medicover AB's overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Medicover AB (LTS:0RPS), the current Notes Receivable is kr0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicover AB (LTS:0RPS) Overvalued in 2026?

Based on GuruFocus' analysis, Medicover AB stock appears to be overvalued. The current stock price of kr238.00 is trading 1.5% above its estimated GF Value™ of kr234.40. GuruFocus considers Medicover AB to be Fairly Valued.

Key valuation signals for LTS:0RPS:

  • Notes Receivable: kr0 Mil
  • GF Value™: kr234.40 vs. price of kr238.00 (1.5% above fair value)
  • GF Score™: 89/100 with 5 warning signs

No single metric tells the full story. See the LTS:0RPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medicover AB Business Description

Address Riddargatan 12A, P.O. Box 5283, Stockholm, SWE, 102 46
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
89GF Score

Get the complete analysis for LTS:0RPS

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr238.00
Price
kr234.40
GF Value